iView Therapeutics

iVIEW Therapeutics, Inc. is a clinical-stage ophthalmic drug development company. It is currently developing a long-acting povidone-iodine eye drop for the treatment of active infections of the conjunctiva and cornea caused by bacteria, mycobacteria, viruses, fungi, or amoebae.